183(top 1%)
12.0K(top 1%)
52(top 1%)
108(top 1%)
all documents
doc citations
citing journals

Top Articles

1Lung cancer: current therapies and new targeted treatmentsLancet, The20172,267
2Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerNature Genetics2012906
3Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung CancerJournal of Thoracic Oncology2012585
4Small-cell lung cancer: what we know, what we need to know and the path forwardNature Reviews Cancer2017558
5New and emerging targeted treatments in advanced non-small-cell lung cancerLancet, The2016381
6Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLCNature Reviews Clinical Oncology2019347
7Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001Annals of Oncology2019339
8High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung CancerJournal of Clinical Oncology2002264
9New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directionsClinical Cancer Research1998232
10Scientific Advances in Lung Cancer 2015Journal of Thoracic Oncology2016231
11Treating ALK-positive lung cancer—early successes and future challengesNature Reviews Clinical Oncology2012224
12ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaperNature Reviews Clinical Oncology2020218
13Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung CancerCancer Immunology Research2019217
14RAS Mutations in Human Melanoma: A Marker of Malignant ProgressionJournal of Investigative Dermatology1994180
15The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016Journal of Thoracic Oncology2016173
16Non-invasive Breath Analysis of Pulmonary NodulesJournal of Thoracic Oncology2012166
17Classification of lung cancer histology by gold nanoparticle sensorsNanomedicine: Nanotechnology, Biology, and Medicine2012162
18Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II TrialCancer Discovery2021154
19Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung CancerOncologist2015151
20ZEB1-responsive genes in non-small cell lung cancerCancer Letters2011147
21Current Status of Src Inhibitors in Solid Tumor MalignanciesOncologist2011139
22Current Status and Future Perspectives on Neoadjuvant Therapy in Lung CancerJournal of Thoracic Oncology2018133
23HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation ConsortiumCancer2017132
24Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patientsNature Communications2019131
25Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung CancerJournal of Thoracic Oncology2012124
26Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic CancerOncologist2015123
27Interferon in the Treatment of Cutaneous T-cell LymphomaHematology/Oncology Clinics of North America1995121
28Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanomaMelanoma Research2017121
29Molecular prognostic markers for adult acute myeloid leukemia with normal cytogeneticsJournal of Hematology and Oncology2009119
30Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or LymphomasClinical Cancer Research2022119
31Comprehensive Genomic Landscapes in Early and Later Onset Colorectal CancerClinical Cancer Research2019116
32MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation ConsortiumJournal of Thoracic Oncology2019115
33Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012Journal of Thoracic Oncology2013113
34Identification of Multiple Nuclear Factors That Interact with Cyclic Adenosine 3′,5′-Monophosphate Response Element-Binding Protein and Activating Transcription Factor-2 by Protein-Protein InteractionsMolecular Endocrinology1991110
35BRCA1andBRCA2Mutation Testing in Young Women With Breast CancerJAMA Oncology2016105
36A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic CancersClinical Cancer Research201896
37The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markersBritish Journal of Cancer201295
38Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancerMolecular Cancer201495
39The Impact of Postoperative Radiotherapy for Thymoma and Thymic CarcinomaJournal of Thoracic Oncology201794
40Scientific Advances and New Frontiers in Mesothelioma TherapeuticsJournal of Thoracic Oncology201887
41Phase I Study of DMOT4039A, an Antibody–Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian CancerMolecular Cancer Therapeutics201685
42A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomasCancer200578
43The Insulin-Like Growth Factor Pathway in Lung CancerJournal of Thoracic Oncology200878
44Epidermal growth factor receptor immunohistochemistryCancer200869
45Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint.Proceedings of the National Academy of Sciences of the United States of America199368
46Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancerCancer201368
47Hepatic complications of breast cancerLancet Oncology, The200967
48Melatonin therapy of advanced human malignant melanomaMelanoma Research199164
49Acupuncture: Role in Comprehensive Cancer Care—A Primer for the Oncologist and Review of the LiteratureIntegrative Cancer Therapies200562
50Oxaliplatin-Induced Neuropathy in Colorectal CancerJournal of Oncology201161